期刊文献+

甲状腺微小乳头状癌淋巴结转移和腺外侵犯的危险因素分析 被引量:6

Risk factors for lymph node metastasis and extra-glandular invasion in thyroid micropapillary carcinoma
原文传递
导出
摘要 目的研究甲状腺微小乳头状癌(PTMC)中央区淋巴结转移(CLNM)及腺外侵犯(ETE)的危险因素。方法回顾性分析2017年5月至2019年12月首次就诊行甲状腺手术的157例PTMC患者资料,所有患者术中均行中央区淋巴结清扫,术后病理明确ETE发生情况。采用SPSS 25.0统计软件进行分析,将与CLNM及ETE相关的临床病理因素进行单因素及logstic多因素回归分析,P<0.05差异有统计学意义。结果157例PTMC患者45例(28.7%)发生CLNM,23例(14.6%)发生ETE。将单因素分析中有意义的因素纳入logstic多因素回归分析,显示:年龄<55岁、男性、BRAFV600E基因突变阳性、肿瘤直径>5 mm、双侧腺叶多灶及被膜侵犯是影响CLNM的独立危险因素(P<0.05);肿瘤直径>5 mm、双侧腺叶多灶是影响ETE的独立危险因素(P<0.05)。结论年龄<55岁、男性、BRAFV600E基因突变阳性、肿瘤直径>5 mm、双侧腺叶多灶及被膜侵犯是影响CLNM的独立危险因素,肿瘤直径>5 mm、双侧腺叶多灶是影响ETE的独立危险因素。 Objective To investigate the risk factors for central lymph node metastasis(CLNM)and extra-glandular invasion(ETE)in minimal papillary thyroid carcinoma(PTMC).Methods Retrospective analysis was performed on the data of 157 patients with PTMC who received thyroid surgery for the first time from May 2017 to December 2019.All patients underwent central lymph node dissection during surgery,and the occurrence of ETE was determined by postoperative pathology.SPSS 25.0 statistical software was used for analysis.Univariate and logstic multivariate regression analysis was performed on the clinicopathological factors related to CLNM and ETE,and the difference was statistically significant at P<0.05.Results CLNM occurred in 45(28.7%)of 157 PTMC patients,and ETE occurred in 23(14.6%)patients.Logstic multivariate regression analysis showed that age<55 years old,male,BRAF V600E gene mutation positive,tumor diameter>5 mm,bilateral multifocal glandular lobes and capsule invasion were independent risk factors for CLNM(P<0.05).Tumor diameter was>5 mm and bilateral glandular lobes were independent risk factors for ETE(P<0.05).Conclusion Age<55 years old,male,positive BRAFV600E gene mutation positive,tumor diameter>5 mm,bilateral glandular leaves and capsule invasion are independent risk factors for CLNM,tumor diameter>5 mm,bilateral multiple foci of glandular leaves are independent risk factors for ETE.
作者 吴元清 林杰 罗佳宝 邱堃 黄平 Wu Yuanqing;Lin Jie;Luo Jiabao;Qiu Kun;Hong Ping(General Surgery,Second People’s Hospital of Hainan Province Hainan Wuzhishan 572299;General Surgery Department,Hainan Provincial People’s Hospital Hainan Haikou 570311)
出处 《中华普外科手术学杂志(电子版)》 2021年第3期319-322,共4页 Chinese Journal of Operative Procedures of General Surgery(Electronic Edition)
基金 海南省自然科学基金项目(ZDYF2018152) 2020年度海南省卫生健康行业科研项目(20A200106)。
关键词 甲状腺肿瘤 乳头状 中央区淋巴结转移 腺外侵犯 Thyroid neoplasms Carcinoma,papillary Central lymph node metastasis Extraglandular invasion
  • 相关文献

参考文献11

二级参考文献141

  • 1盖宝东,郑泽霖,张德恒,王树地.169例结节性甲状腺肿与甲状腺癌并存的诊治体会[J].中国普外基础与临床杂志,2004,11(6):496-497. 被引量:24
  • 2殷德涛,王庆兆.分化型甲状腺癌的治疗[J].中国普通外科杂志,2007,16(1):7-9. 被引量:38
  • 3吴延升,张仑,王旭东,张文超.甲状腺乳头状癌预后多因素分析[J].中国肿瘤临床,2007,34(22):1294-1297. 被引量:34
  • 4GANLY I, NIXON I J, WANG L Y, et al. Survival fromdifferentiated thyroid cancer: What has age got to do with it?[J]Thyroid, 2015, 25(10): 1106-1114.
  • 5National Cancer Institute. SEER Cancer Statistics Factsheets:Thyroid Cancer. [EB/OL]. http://seer.cancer.gov/statfacts/html/thyro.html, 2015-10-08.
  • 6DAVIES L, WELCH H G. Increasing incidence of thyroidcancer in the United States, 1973-2002 [J]. JAMA, 2006,295(18): 2164-2167.
  • 7MAZZAFERRI E L. Management of low-risk differentiatedthyroid cancer [J]. Endocr Pract, 2007, 13(5): 498-512.
  • 8ROTI E, DEGLI UBERTI E C, BONDANELLI M, et al.Thyroid papillary microcarcinoma: a descriptive and metaanalysisstudy [J]. Eur J Endocrinol, 2008, 159(6): 659-673.
  • 9ITO Y, KUDO T, KIHARA M, et al. Prognosis of low-riskpapillary thyroid carcinoma patients: its relationship with thesize of primary tumors [J]. Endocr J, 2012, 59(2): 119-125.
  • 10WU M H, SHEN W T, GOSNELL J, et al. Prognosticsignificance of extranodal extension of regional lymphnode metastasis in papillary thyroid cancer [J]. HeadNeck, 2015, 37(9): 1336- 1343.

共引文献613

同被引文献79

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部